News and Views
Nature Medicine 14, 369 - 370 (2008)
doi:10.1038/nm0408-369
Getting personal about treating HIV
James D Neaton1 & H Clifford Lane2
- James D. Neaton is in the Division of Biostatistics, School of Public Health, University of Minnesota, 2221 University Avenue Southeast, Room 200, Minneapolis, Minnesota 55414, USA.
- H. Clifford Lane is at the US National Institutes of Health, Building 10, Room 4-1479, 9000 Rockville Pike, Bethesda, Maryland 20892, USA. e-mail: jim@ccbr.umn.edu
Abstract
Genetic variants have been identified that may predict the response to HIV treatment (pages 413–420).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1?infected individualsNature Medicine Article (01 Apr 2008)
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanismsNature Immunology Article (01 Dec 2007)
See all 5 matches for Research
